Advanced search
Publication Cover
Modern Rheumatology Volume 17, 2007 - Issue 4
Journal homepage
26
Views
23
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Imatinib mesylate both prevents and treats the arthritis induced by type II collagen antibody in mice

Kensuke KoyamaDepartment of Immunology, Faculty of Medicine, University of Yamanashi,Yamanashi, Japan;Department of Orthopaedic Surgery, Faculty of Medicine, University of Yamanashi,1110 Shimokato, Chuo, Yamanashi 409-3898, JapanCorrespondence[email protected]
,
Kyosuke HatsushikaDepartment of Immunology, Faculty of Medicine, University of Yamanashi,Yamanashi, Japan
,
Takashi AndoDepartment of Immunology, Faculty of Medicine, University of Yamanashi,Yamanashi, Japan
,
Michitomo SakumaDepartment of Immunology, Faculty of Medicine, University of Yamanashi,Yamanashi, Japan
,
Masanori WakoDepartment of Immunology, Faculty of Medicine, University of Yamanashi,Yamanashi, Japan
,
Ryohei KatoDepartment of Human Pathology, Faculty of Medicine, University of Yamanashi,Yamanashi, Japan
,
Hirotaka HaroDepartment of Orthopaedic Surgery, Faculty of Medicine, University of Yamanashi,1110 Shimokato, Chuo, Yamanashi 409-3898, Japan
,
Hajime SugiyamaDepartment of Orthopaedic Surgery, Faculty of Medicine, University of Yamanashi,1110 Shimokato, Chuo, Yamanashi 409-3898, Japan
,
Yoshiki HamadaDepartment of Orthopaedic Surgery, Faculty of Medicine, University of Yamanashi,1110 Shimokato, Chuo, Yamanashi 409-3898, Japan
,
Hideoki OgawaAtopy Research Center, Juntendo University School of Medicine,Tokyo, Japan
&
Atsuhito NakaoAtopy Research Center, Juntendo University School of Medicine,Tokyo, Japan
 show all
Pages 306-310 | Received 08 Feb 2007, Accepted 01 May 2007, Published online: 02 Jan 2014

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Nicole J. Horwood, Ania M. Urbaniak & Lynett Danks. (2012) Tec Family Kinases in Inflammation and Disease. International Reviews of Immunology 31:2, pages 87-103.
Read now
Naotsugu Akashi, Isao Matsumoto, Yoko Tanaka, Asuka Inoue, Kayo Yamamoto, Naoto Umeda, Yuki Tanaka, Taichi Hayashi, Daisuke Goto, Satoshi Ito, Kaneo Sekiguchi & Takayuki Sumida. (2011) Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis. Modern Rheumatology 21:3, pages 267-275.
Read now
Fumitaka Terabe, Masayasu Kitano, Mari Kawai, Yusuke Kuwahara, Toru Hirano, Junsuke Arimitsu, Keisuke Hagihara, Yoshihito Shima, Masashi Narazaki, Toshio Tanaka, Ichiro Kawase, Hajime Sano & Atsushi Ogata. (2009) Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway. Modern Rheumatology 19:5, pages 522-529.
Read now
Zoltán Szekanecz, Timea Besenyei, György Paragh & Alisa E. Koch. (2009) Angiogenesis in rheumatoid arthritis. Autoimmunity 42:7, pages 563-573.
Read now

Articles from other publishers (19)

Shivani Yadav, Astik Priya, Diksha R. Borade & Reena Agrawal-Rajput. (2022) Macrophage subsets and their role: co-relation with colony-stimulating factor-1 receptor and clinical relevance. Immunologic Research 71:2, pages 130-152.
Crossref
Mahipal Reddy Donthi, Ranendra Narayan Saha, Gautam Singhvi & Sunil Kumar Dubey. (2023) Dasatinib-Loaded Topical Nano-Emulgel for Rheumatoid Arthritis: Formulation Design and Optimization by QbD, In Vitro, Ex Vivo, and In Vivo Evaluation. Pharmaceutics 15:3, pages 736.
Crossref
Lydia Ntari, Christoforos Nikolaou, Ksanthi Kranidioti, Dimitra Papadopoulou, Eleni Christodoulou-Vafeiadou, Panagiotis Chouvardas, Florian Meier, Christina Geka, Maria C. Denis, Niki Karagianni & George Kollias. (2021) Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment. Journal of Translational Medicine 19:1.
Crossref
Se Hwan Mun, Peter Sang Uk Park & Kyung-Hyun Park-Min. (2020) The M-CSF receptor in osteoclasts and beyond. Experimental & Molecular Medicine 52:8, pages 1239-1254.
Crossref
Qian Wang, Christin M Lepus, Harini Raghu, Laurent L Reber, Mindy M Tsai, Heidi H Wong, Ericka von Kaeppler, Nithya Lingampalli, Michelle S Bloom, Nick Hu, Eileen E Elliott, Francesca Oliviero, Leonardo Punzi, Nicholas J Giori, Stuart B Goodman, Constance R Chu, Jeremy Sokolove, Yoshihiro Fukuoka, Lawrence B Schwartz, Stephen J Galli & William H Robinson. (2019) IgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis. eLife 8.
Crossref
X Hu, J Tang, X Hu, P Bao, J Pan, Y Ou, W Deng & Y Liang. (2019) Imatinib inhibits CSF1R that stimulates proliferation of rheumatoid arthritis fibroblast-like synoviocytes. Clinical and Experimental Immunology 195:2, pages 237-250.
Crossref
Hatem A. Elshabrawy, Zhenlong Chen, Michael V. Volin, Shalini Ravella, Shanti Virupannavar & Shiva Shahrara. (2015) The pathogenic role of angiogenesis in rheumatoid arthritis. Angiogenesis 18:4, pages 433-448.
Crossref
Zoltan Szekanecz & Alisa E. Koch. 2013. Kelley's Textbook of Rheumatology. Kelley's Textbook of Rheumatology 358 368.e5 .
Jennifer L. Rogers, Donald S. Serafin, Roman G. Timoshchenko & Teresa K. Tarrant. (2012) Cellular Targeting in Autoimmunity. Current Allergy and Asthma Reports 12:6, pages 495-510.
Crossref
Jing Jin GuCatherine P. LavauElena PugachevaErik J. SoderblomM. Arthur MoseleyAnn Marie Pendergast. (2012) Abl Family Kinases Modulate T Cell–Mediated Inflammation and Chemokine-Induced Migration Through the Adaptor HEF1 and the GTPase Rap1. Science Signaling 5:233.
Crossref
Yvonne Y. Li, Jianghong An & Steven J. M. Jones. (2011) A Computational Approach to Finding Novel Targets for Existing Drugs. PLoS Computational Biology 7:9, pages e1002139.
Crossref
Mats Dehlin, Sofia Andersson, Malin Erlandsson, Mikael Brisslert & Maria Bokarewa. (2011) Inhibition of fms-like tyrosine kinase 3 alleviates experimental arthritis by reducing formation of dendritic cells and antigen presentation. Journal of Leukocyte Biology 90:4, pages 811-817.
Crossref
Zoltán Szekanecz, Timea Besenyei, Ágnes Szentpétery & Alisa E Koch. (2010) Angiogenesis and vasculogenesis in rheumatoid arthritis. Current Opinion in Rheumatology 22:3, pages 299-306.
Crossref
Fumitaka Terabe, Masayasu Kitano, Mari Kawai, Yusuke Kuwahara, Toru Hirano, Junsuke Arimitsu, Keisuke Hagihara, Yoshihito Shima, Masashi Narazaki, Toshio Tanaka, Ichiro Kawase, Hajime Sano & Atsushi Ogata. (2009) Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway. Modern Rheumatology 19:5, pages 522-529.
Crossref
Valder R Arruda, Patricia Favaro & Jonathan D Finn. (2009) Strategies to Modulate Immune Responses: A New Frontier for Gene Therapy. Molecular Therapy 17:9, pages 1492-1503.
Crossref
Matthew R. Vernon, Larry Pearson & Ehab Atallah. (2009) Resolution of Rheumatoid Arthritis Symptoms With Imatinib Mesylate. JCR: Journal of Clinical Rheumatology 15:5, pages 267.
Crossref
Christina D'Aura Swanson, Ricardo T. Paniagua, Tamsin M. Lindstrom & William H. Robinson. (2009) Tyrosine kinases as targets for the treatment of rheumatoid arthritis. Nature Reviews Rheumatology 5:6, pages 317-324.
Crossref
Cédric LouvetGregory L. SzotJiena LangMichael R. LeeNicolas MartinierGideon Bollag, Shirley ZhuArthur Weiss & Jeffrey A. Bluestone. (2008) Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice. Proceedings of the National Academy of Sciences 105:48, pages 18895-18900.
Crossref
Essa Hu, Andrew Tasker, Ryan D. White, Roxanne K. Kunz, Jason Human, Ning Chen, Roland Bürli, Randall Hungate, Perry Novak, Andrea Itano, Xuxia Zhang, Violeta Yu, Yen Nguyen, Yanyan Tudor, Matthew Plant, Shaun Flynn, Yang Xu, Kristin L. Meagher, Douglas A. Whittington & Gordon Y. Ng. (2008) Discovery of Aryl Aminoquinazoline Pyridones as Potent, Selective, and Orally Efficacious Inhibitors of Receptor Tyrosine Kinase c-Kit. Journal of Medicinal Chemistry 51:11, pages 3065-3068.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.